FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
Go back to FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia| PACIRA (NASDAQ: PCRX) | Delayed: 22.71 +0.38 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.33 | 52 Week High | $80.25 | |||
| Open | $22.21 | 52 Week Low | $30.25 | |||
| Day High | $22.84 | P/E | N/A | |||
| Day Low | $22.00 | EPS | $-2.08 | |||
| Volume | 706,850 | |||||
| PACIRA (NASDAQ: PCRX) | Delayed: 22.71 +0.38 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.33 | 52 Week High | $80.25 | |||
| Open | $22.21 | 52 Week Low | $30.25 | |||
| Day High | $22.84 | P/E | N/A | |||
| Day Low | $22.00 | EPS | $-2.08 | |||
| Volume | 706,850 | |||||

